Is Memantine a Potential Therapeutic for Rett Syndrome?
Memantine is a low-affinity voltage-dependent non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist. It is classified as a neuroprotective aminoadamantane. It does not cure or reverse Alzheimer’s but it does effectively treat symptoms, slows the progression of the disease and allows many p...
Main Authors: | Olivia eBello, Kelsey eBlair, Christopher eChapleau, Jennifer eLarimore |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-12-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnins.2013.00245/full |
Similar Items
-
The role of Memantine in slowing cognitive decline in patients with Down syndrome–A systematic review and meta analysis
by: Zarmina Islam, et al.
Published: (2024-03-01) -
Animal models of intellectual disability: towards a translational approach
by: Carla A. Scorza, et al.
Published: (2011-01-01) -
Editorial: Innovative approaches and therapeutic perspectives for early-onset neurodevelopmental disorders: from bench to bedside
by: Barbara Bardoni, et al.
Published: (2024-02-01) -
Brain Mitochondrial Bioenergetics in Genetic Neurodevelopmental Disorders: Focus on Down, Rett and Fragile X Syndromes
by: Daniela Valenti, et al.
Published: (2023-08-01) -
Downs : the history of a disability /
by: Wright, David, 1965-
Published: (c201)